BRPI0918997A2 - agent for preventing and / or treating a functional gastrointestinal disorder. - Google Patents
agent for preventing and / or treating a functional gastrointestinal disorder.Info
- Publication number
- BRPI0918997A2 BRPI0918997A2 BRPI0918997A BRPI0918997A BRPI0918997A2 BR PI0918997 A2 BRPI0918997 A2 BR PI0918997A2 BR PI0918997 A BRPI0918997 A BR PI0918997A BR PI0918997 A BRPI0918997 A BR PI0918997A BR PI0918997 A2 BRPI0918997 A2 BR PI0918997A2
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- preventing
- agent
- gastrointestinal disorder
- functional gastrointestinal
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/10—Laxatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008248932 | 2008-09-26 | ||
| PCT/JP2009/066533 WO2010035751A1 (en) | 2008-09-26 | 2009-09-24 | Prophylactic and/or therapeutic agent for functional gastrointestinal disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0918997A2 true BRPI0918997A2 (en) | 2015-12-01 |
Family
ID=42059749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0918997A BRPI0918997A2 (en) | 2008-09-26 | 2009-09-24 | agent for preventing and / or treating a functional gastrointestinal disorder. |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US8980872B2 (en) |
| EP (1) | EP2327407B1 (en) |
| JP (1) | JP5567484B2 (en) |
| KR (1) | KR20110071096A (en) |
| CN (1) | CN102164599B (en) |
| AU (1) | AU2009297562B2 (en) |
| BR (1) | BRPI0918997A2 (en) |
| CA (1) | CA2736285C (en) |
| DK (1) | DK2327407T3 (en) |
| ES (1) | ES2496190T3 (en) |
| PL (1) | PL2327407T3 (en) |
| PT (1) | PT2327407E (en) |
| RU (1) | RU2011116400A (en) |
| WO (1) | WO2010035751A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITBO20050123A1 (en) | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | GASTRORESISTIC PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMINA |
| AU2010312309B2 (en) | 2009-10-26 | 2016-10-06 | Thomas Julius Borody | Novel enteric combination therapy |
| JP7280069B2 (en) | 2018-03-28 | 2023-05-23 | 森永乳業株式会社 | A composition for preventing or improving functional gastrointestinal disorders, and pharmaceutical compositions and food and drink compositions using the composition for preventing or improving functional gastrointestinal disorders |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1154655B (en) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | IMIDAZO-RIFAMYCIN DERIVATIVES METHODS FOR THEIR PREPARATION AND USE AS AN ANTIBACTERIAL ACTION SUBSTANCE |
| JPS6123192A (en) | 1984-07-11 | 1986-01-31 | 三菱電機株式会社 | Manufacture of matrix type display unit |
| IT1253711B (en) | 1991-12-17 | 1995-08-23 | Alfa Wassermann Spa | VAGINAL PHARMACEUTICAL FORMULATIONS CONTAINING RIFAXIMIN AND THEIR USE IN THE TREATMENT OF VAGINAL INFECTIONS |
| IT1264494B1 (en) | 1993-03-23 | 1996-09-24 | Alfa Wassermann Spa | USE OF RIFAXIMIN AND FORMULATIONS THAT CONTAIN IT IN THE TREATMENT OF GASTRIC DYSPEPSIES ORIGINATED BY HELICOBACTER |
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| IT1290679B1 (en) | 1997-02-14 | 1998-12-10 | Alfa Wassermann Spa | USE OF RIFAXIMINE AND OF THE PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT IN THE TREATMENT OF DIARRHEA FROM CRYPTOSPORIDIOSIS. |
| ITMI20032144A1 (en) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | REFLEXIMINE POLIMORPHIC FORMS, PROCESSES TO OBTAIN THEM AND |
| PT1698630E (en) | 2005-03-03 | 2014-09-15 | Alfa Wassermann Spa | New polymorphous forms of rifaximin, processes for their production and use thereof in the medicinal preparations |
| US20090233888A1 (en) * | 2005-03-23 | 2009-09-17 | Usc Stevens, University Of Southern California | Treatment of disease conditions through modulation of hydrogen sulfide produced by small intestinal bacterial overgrowth |
| PT1996710T (en) * | 2006-03-09 | 2019-10-25 | Salix Pharmaceuticals Inc | Rifaximin anti-rectal dysfunction preparation |
| BRPI0714724A8 (en) * | 2006-08-02 | 2018-04-10 | Salix Pharmaceuticals Inc | methods for treating enteritis, to protect against enteritis, against colonic mucosal damage and radiation-induced colorectal inflammation, to treat enteritis in an individual or to monitor the progress of an individual who is treated for enteritis, to select an individual to treat enteritis, and to treat diarrhea prophylactically. |
-
2009
- 2009-09-24 US US13/061,239 patent/US8980872B2/en active Active
- 2009-09-24 EP EP09816166.4A patent/EP2327407B1/en active Active
- 2009-09-24 ES ES09816166.4T patent/ES2496190T3/en active Active
- 2009-09-24 BR BRPI0918997A patent/BRPI0918997A2/en not_active Application Discontinuation
- 2009-09-24 KR KR1020117009342A patent/KR20110071096A/en active Search and Examination
- 2009-09-24 PL PL09816166T patent/PL2327407T3/en unknown
- 2009-09-24 RU RU2011116400/15A patent/RU2011116400A/en unknown
- 2009-09-24 CN CN200980137540.1A patent/CN102164599B/en active Active
- 2009-09-24 DK DK09816166.4T patent/DK2327407T3/en active
- 2009-09-24 AU AU2009297562A patent/AU2009297562B2/en active Active
- 2009-09-24 CA CA2736285A patent/CA2736285C/en active Active
- 2009-09-24 PT PT98161664T patent/PT2327407E/en unknown
- 2009-09-24 JP JP2010530854A patent/JP5567484B2/en active Active
- 2009-09-24 WO PCT/JP2009/066533 patent/WO2010035751A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| WO2010035751A1 (en) | 2010-04-01 |
| PT2327407E (en) | 2014-09-10 |
| JPWO2010035751A1 (en) | 2012-02-23 |
| EP2327407A1 (en) | 2011-06-01 |
| DK2327407T3 (en) | 2014-08-25 |
| PL2327407T3 (en) | 2014-12-31 |
| CA2736285A1 (en) | 2010-04-01 |
| EP2327407A4 (en) | 2012-02-29 |
| AU2009297562B2 (en) | 2015-04-23 |
| US20110152517A1 (en) | 2011-06-23 |
| CN102164599B (en) | 2014-07-23 |
| CN102164599A (en) | 2011-08-24 |
| US8980872B2 (en) | 2015-03-17 |
| JP5567484B2 (en) | 2014-08-06 |
| RU2011116400A (en) | 2012-11-10 |
| CA2736285C (en) | 2016-08-23 |
| EP2327407B1 (en) | 2014-07-09 |
| KR20110071096A (en) | 2011-06-28 |
| ES2496190T3 (en) | 2014-09-18 |
| AU2009297562A1 (en) | 2010-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI0923823A2 (en) | Collaboration Agent. | |
| BRPI0916576A2 (en) | at least one chemical entity, pharmaceutical composition, and method for treating a condition or disorder. | |
| BR112012004333A2 (en) | compound, pharmaceutical composition, and method for treating or preventing a disease or disorder. | |
| BRPI0916472A2 (en) | wound treatment device, wound treatment method and wound treatment device | |
| BRPI0915382A2 (en) | compound, pharmaceutical composition, and method for treating a disease or disorder. | |
| JP2009039101A5 (en) | ||
| BRPI0915433A2 (en) | method and device. | |
| BRPI0817664A2 (en) | Nanoparticles, method for preparing nanoparticles and method for therapeutically or prophylactically treating an individual | |
| BRPI0923171A2 (en) | Prevention and treatment of rotavirus diarrhea. | |
| BRPI0911757A2 (en) | compositions and methods for treating digestive disorders. | |
| BR112012018951A2 (en) | pharmaceutical composition, pharmaceutical combination and method for treating and / or preventing cancer and antibody | |
| BRPI0913447A2 (en) | ester composition and personal care composition. | |
| BR112012018947A8 (en) | pharmaceutical composition for treating and / or preventing cancer, antibody, pharmaceutical combination and method for treating and / or preventing cancer | |
| BRPI0918061A2 (en) | systems, devices and methods for triggering and / or controlling devices, for example transdermal delivery devices | |
| BRPI1007990A2 (en) | Specific diaryl hydantoin and diarylthioidantoin compounds. | |
| BRPI0812508A2 (en) | Device and process for controlling a brake device. | |
| BRPI0823030A2 (en) | Elevator system, and, method for making elevator system. | |
| BRPI0906611A2 (en) | Implantable products comprising nanoparticles. | |
| FI20070486A (en) | Elevator security | |
| BRPI0807906A2 (en) | TOKEN PERSONAL HAVING COMMUNICATION SKILLS IMPROVED FOR A HOSTED APPLICATION. | |
| BRPI0816318A2 (en) | Transdermal delivery device, and method for preparing the same | |
| BRPI0922066A2 (en) | processes for the manufacture of methylmercaptopropionaldehyde and methionine or methionine hydroxyanalogue, methylmercaptopropinaldehyde, methionine or methionine hydroxyanalogue, and use of methionine or methionine hydroxyanalogue. | |
| BRPI1006145A2 (en) | "composition and method for treating diabetes". | |
| BRPI0916000A2 (en) | modified release pharmaceutical formulation, and method for treating a disorder | |
| BRPI0820794A2 (en) | Resin composition, resin and textile |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25A | Requested transfer of rights approved |
Owner name: ALFA WASSERMANN S.P.A (IT) |
|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL |